VIOG - ETF AI Analysis
Top Page
Vanguard S&P Small-Cap 600 Growth ETF (VIOG)
VIOG, the Vanguard S&P Small-Cap 600 Growth ETF, earns a solid overall rating thanks to strong contributors like Alkermes, Zurn Water Solutions, Federal Signal, and Armstrong World, which all show robust financial performance, positive earnings call sentiment, and strategic growth initiatives. These strengths are partly offset by weaker names such as Etsy and ViaSat, where profitability challenges, high leverage, and signs of overvaluation introduce more risk. The main risk factor is that several holdings show valuation and technical caution, which can make the fund more sensitive to market pullbacks in small-cap growth stocks.
VIOG vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.07B
- Region
- North America
- Expense Ratio
- 0.10%
- Beta
- 0.93
- Issuer
- Vanguard
- Inception Date
- Sep 07, 2010
- Dividend Yield
- 0.76%
- Asset Class
- Equity
- Index Tracked
- S&P Small Cap 600 Growth
VIOG Summary
Vanguard S&P Small-Cap 600 Growth ETF (VIOG) is a fund that follows the S&P Small Cap 600 Growth index, focusing on smaller U.S. companies with strong growth potential. It spreads your money across many industries, including technology, health care, and industrials. Some recognizable holdings include Etsy and ViaSat, along with a wide mix of other small but fast-growing businesses. Investors might consider VIOG if they want long-term growth and diversification beyond large, well-known companies. A key risk is that small-cap growth stocks can be more volatile, so the ETF’s value can move up and down sharply with the market.
How much will it cost me?
This ETF has an expense ratio of 0.10%, which means you’ll pay about $1 per year for every $1,000 you invest. That’s lower than the average ETF because it’s a passively managed fund that simply tracks the S&P Small-Cap 600 Growth Index, keeping costs down.
What would affect this ETF?
VIOG could benefit if the U.S. economy stays healthy, interest rates eventually ease, and innovation-driven sectors like technology, health care, and industrials continue to grow, supporting its small-cap growth companies such as Protagonist Therapeutics, Etsy, and ViaSat. On the downside, higher-for-longer interest rates, an economic slowdown in the U.S., or tighter regulations on areas like health care and tech could hurt smaller, growth-focused businesses and make this ETF more volatile.
VIOG Top 10 Holdings
VIOG leans into U.S. small-cap growth, with health care and tech names doing much of the heavy lifting. Glaukos and TG Therapeutics have been rising sharply, giving the fund a strong biotech tilt, while Protagonist Therapeutics and Alkermes add more steady momentum to that theme. On the consumer side, Etsy has rebounded and is helping performance, even as questions linger about its long-term growth engine. Industrial exposure is more mixed: Zurn Water Solutions and Armstrong World have been lagging, acting as mild brakes on an otherwise energetic small-cap portfolio.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 VSAT | ViaSat | 1.23% | $13.08M | $10.21B | 95.94% | 56Neutral |
 GKOS | Glaukos | 1.17% | $12.48M | $14.12B | 166.67% | 61Neutral |
 PTGX | Protagonist Therapeutics | 1.08% | $11.55M | $9.02B | 84.65% | 68Neutral |
 RHP | Ryman | 1.11% | $11.79M | $9.20B | 52.81% | 66Neutral |
 TGTX | TG Therapeutics | 1.02% | $10.89M | $9.18B | 80.32% | 65Neutral |
 ETSY | Etsy | 0.95% | $10.11M | $7.97B | 47.12% | 57Neutral |
 ALKS | Alkermes | 0.91% | $9.65M | $7.53B | 51.44% | 80Outperform |
 FSS | Federal Signal | 0.86% | $9.15M | $7.14B | 1.59% | 76Outperform |
 AWI | Armstrong World | 0.87% | $9.26M | $7.16B | -11.14% | 77Outperform |
 ZWS | Zurn Water Solutions | 0.79% | $8.45M | $7.37B | -6.21% | 79Outperform |
VIOG Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VIOG, the sentiment is Positive. The current price of 142.54 is above the 20-day moving average (MA) of 139.71, above the 50-day MA of 141.39, and above the 200-day MA of 138.63, indicating a bullish trend. The MACD of 0.32 indicates Negative momentum. The RSI at 57.30 is Neutral, neither overbought nor oversold. The STOCH value of 71.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VIOG.
VIOG Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| VIOG | $142.54 | $154.00(8.04% Upside) | $1.07B | 0.10% | 68Neutral |
 FNDA | $36.26 | $43.38(19.64% Upside) | $8.99B | 0.25% | 68Neutral |
 IJT | $165.68 | $204.83(23.63% Upside) | $7.46B | 0.18% | 68Neutral |
 SLYG | $110.58 | $137.07(23.95% Upside) | $4.69B | 0.15% | 68Neutral |
 VTWG | $257.04 | $371.59(44.57% Upside) | $1.40B | 0.06% | 61Neutral |
 FYC | $113.52 | $149.61(31.79% Upside) | $1.33B | 0.70% | 61Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 142.54 | 23.02 | 19.26% | |
| FNDA | Schwab Fundamental US Small Co. Index ETF | 36.26 | 5.92 | 19.50% | |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 165.68 | 26.43 | 18.98% | |
| SLYG | SPDR S&P 600 Small Cap Growth ETF | 110.58 | 17.74 | 19.11% | |
| VTWG | Vanguard Russell 2000 Growth ETF | 257.04 | 19.84 | 8.36% | |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 113.52 | 19.11 | 20.24% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.